Niva Bupa Health Insurance, formerly known as Max Bupa Health Insurance, is a leading standalone health insurance provider in India. The company offers a wide range of health insurance solutions designed to cater to the diverse needs of individuals, families, and corporates. Known for its customer-centric approach, innovative products, and hassle-free claims process, Niva Bupa is committed to making healthcare accessible and affordable for everyone. As of December, 06, 2024, the Niva Bupa Share Price Target 2025, 2030, 2035, 2040 share price on the NSE is ₹94.50. Below are the projected Niva Bupa Share Price Target 2025, 2030, 2035, 2040 share price targets for the years 2024, 2025, 2026, 2027, 2030, 2035 And 2040.
Additionally, feel free to join our – Tele-(g)ram) where we share Fast stock market news and updates➥https://bit.ly/TradeWatch360
Niva Bupa Health Insurance Company Overview
Established in 2010, Niva Bupa Health Insurance is a joint venture between Fettle Tone LLP, a True North entity, and Bupa, a global healthcare company based in the UK. Headquartered in New Delhi, the company offers comprehensive health insurance plans, including individual health policies, family floater plans, top-up covers, and critical illness insurance. Niva Bupa is recognized for its extensive network of over 8,000 empaneled hospitals, enabling seamless cashless treatment across India.
| Company type | Public |
| Traded as | NSE: NIVABUPA BSE: 544286 |
| Industry | Insurance |
| Founded | 2008; 16 years ago |
| Headquarters | New Delhi, India |
| Area served | India |
| Key people | Krishnan Ramachandran, Maninder Singh Juneja, David Fletcher, Chandrashekhar Bhaskar Bhave |
| Services | Health insurance |
| Revenue | ₹4,115 crore (2024) |
| Net Profit | ₹82 crore (2024) |
| Total assets | ₹7,151 crore(US$44 billion) (2024) |
| Total equity | ₹1,718 crore (2024) |
| Number of employees | 8,555 (2024) |
| Parent | True NorthBupa |
| Website | www.nivabupa.com |
Niva Bupa Share Price Target from 2025-2040 Forecast
| Year | Year High Target (₹) | Year Low Target (₹) | Year-End Target (₹) |
| 2024 | ₹110 | ₹70 | ₹103 |
| 2025 | ₹220 | ₹90 | ₹180 |
| 2026 | ₹260 | ₹140 | ₹230 |
| 2027 | ₹310 | ₹210 | ₹290 |
| 2028 | ₹405 | ₹260 | ₹370 |
| 2029 | ₹500 | ₹330 | ₹430 |
| 2030 | ₹590 | ₹410 | ₹560 |
| 2035 | ₹1370 | ₹510 | ₹1150 |
| 2040 | ₹2150 | ₹950 | ₹1950 |
Technical Analysis for Niva Bupa Health Insurance
Niva Bupa Share Price Target 2025
| Year | 1st Target | 2nd Target |
| 2025 | ₹170 | ₹220 |
Niva Bupa is expected to witness growth in 2025, fueled by its expanding market share in health insurance and increasing healthcare awareness in India. The share price is projected to reach a first target of ₹170 and a second target of ₹220.
Read More: Dr Lal PathLabs Share Price Target 2025, 2030, 2035, 2040
Niva Bupa Share Price Target 2026
| Year | 1st Target | 2nd Target |
| 2026 | ₹240 | ₹260 |
In 2026, the company is anticipated to capitalize on the growing demand for health insurance and its innovative policies. The share price is forecasted to reach ₹240 for the first target and ₹260 for the second target.
Niva Bupa Share Price Target 2027
| Year | 1st Target | 2nd Target |
| 2027 | ₹295 | ₹310 |
By 2027, Niva Bupa is likely to further strengthen its foothold in the health insurance sector, driven by customer-centric services. The share price is expected to reach ₹295 for the first target and ₹310 for the second target.
Niva Bupa Share Price Target 2028
| Year | 1st Target | 2nd Target |
| 2028 | ₹370 | ₹405 |
In 2028, with continued growth in the health insurance sector and strategic partnerships, the company’s share price is projected to reach ₹370 for the first target and ₹405 for the second target.
Niva Bupa Share Price Target 2029
| Year | 1st Target | 2nd Target |
| 2029 | ₹460 | ₹500 |
In 2029, Niva Bupa is expected to benefit from higher penetration of health insurance and rising healthcare costs. The share price is forecasted to reach ₹460 for the first target and ₹500 for the second target.
Niva Bupa Share Price Target 2030
| Year | 1st Target | 2nd Target |
| 2030 | ₹560 | ₹590 |
By 2030, Niva Bupa is likely to expand its customer base significantly, leveraging its brand reputation and innovative offerings. The share price is projected to hit ₹560 for the first target and ₹590 for the second target.
Niva Bupa Share Price Target 2035
| Year | 1st Target | 2nd Target |
| 2035 | ₹1050 | ₹1370 |
Over the next decade, with increasing demand for health insurance and growing market presence, the share price is anticipated to achieve ₹1050 for the first target and ₹1370 for the second target by 2035.
Read More:- Tilaknagar Industries Share Price Target 2025, 2030, 2035, 2040
Niva Bupa Share Price Target 2040
| Year | 1st Target | 2nd Target |
| 2040 | ₹1700 | ₹2150 |
By 2040, Niva Bupa is likely to emerge as a market leader in health insurance, supported by continuous growth in the sector. The share price is expected to reach ₹1700 for the first target and ₹2150 for the second target, reflecting its long-term growth potential.
Niva Bupa Health Insurance Fundamentals
| Parameter | Value |
| Market Cap | ₹17,985 Cr |
| P/E Ratio (TTM) | 218.76 |
| P/B Ratio | 6.27 |
| Industry P/E | 21.69 |
| Debt to Equity | 0.12 |
| ROE | 0.00% |
| EPS (TTM) | 0.45 |
| Dividend Yield | 0.00% |
| 52 Week High | ₹97 |
| 52 Week Low | ₹109 |
| Book Value | 15.71 |
| Face Value | 10 |
Niva Bupa Health Insurance Financial Results
| All In ₹Cr. | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
| Sales | 1,057 | 1,413 | 2,149 | 2,853 | 4,115 |
| Expenses | 1,094 | 1,435 | 2,326 | 3,183 | 4,225 |
| Operating Profit | -37 | -22 | -177 | -330 | -110 |
| OPM % | -3% | -2% | -8% | -12% | -3% |
| Other Income | 0 | 0 | 7 | 374 | 221 |
| Interest | 4 | 6 | 0 | 0 | 0 |
| Depreciation | 21 | 22 | 27 | 32 | 29 |
| Profit before tax | -62 | -50 | -197 | 13 | 82 |
| Tax % | 0% | 0% | 0% | 0% | 0% |
| Net Profit | -62 | -50 | -197 | 13 | 82 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% |
Niva Bupa Health Insurance Balance Sheet
| All In ₹Cr. | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Sep 2024 |
| Equity Capital | 1,350 | 1,409 | 1,511 | 1,700 | 1,718 |
| Reserves | -773 | -903 | -683 | 351 | 344 |
| Borrowings | 0 | 250 | 250 | 250 | 250 |
| Other Liabilities | 1,322 | 1,983 | 2,799 | 3,891 | 4,840 |
| Total Liabilities | 1,899 | 2,738 | 3,877 | 6,192 | 7,151 |
| Fixed Assets | 46 | 49 | 52 | 58 | 0 |
| CWIP | 2 | 1 | 4 | 1 | 0 |
| Investments | 1,622 | 2,401 | 3,366 | 5,458 | 5,965 |
| Other Assets | 230 | 287 | 455 | 675 | 1,186 |
| Total Assets | 1,899 | 2,738 | 3,877 | 6,192 | 7,151 |
Niva Bupa Health Insurance Shareholding Pattern
| Nov 2024 | |
| Promoters | 55.98% |
| FIIs | 8.63% |
| DIIs | 9.57% |
| Public | 25.83% |
| No. of Shareholders | 1,60,440 |
Niva Bupa Health Insurance Peers comparison
| Sector: Insurance | Industry: Finance & Investments | ||||
| Name | P/E | Mar CapRs.Cr. | Div Yld% | NP QtrRs.Cr. | ROCE% |
| Life Insurance | 14.81 | 613398.29 | 1.02 | 7722.74 | 72.95 |
| SBI Life Insurance | 65.36 | 142520.88 | 0.19 | 529.42 | 13.23 |
| HDFC Life Insur. | 81.59 | 138171.62 | 0.31 | 435.18 | 6.61 |
| ICICI Lombard | 43.26 | 96261.94 | 0.31 | 693.95 | 22.52 |
| ICICI Pru Life | 109.74 | 96125.16 | 0.09 | 250.99 | 8.75 |
| General Insuranc | 9.90 | 72044.43 | 2.42 | 1855.71 | 15.78 |
| New India Assura | 24.43 | 33281.36 | 1.01 | 90.62 | 0.56 |
| Niva Bupa Health | 220.89 | 18076.65 | 0.00 | 13.02 | 4.85 |
FAQs
Q.1. What is the share price target for Niva Bupa Health Insurance in 2025?
Ans: The expected share price target for 2025 is ₹170 as the first target and ₹220 as the second target. This reflects the growing demand for health insurance and Niva Bupa’s market presence.
Q.2. What are the projected share price targets for Health Insurance in 2026?
Ans: For 2026, the share price is expected to reach ₹240 as the first target and ₹260 as the second target, driven by the increasing penetration of health insurance in India.
Q.3. What is the anticipated share price target for Niva Bupa Health Insurance in 2027?
Ans: In 2027, the projected share price is ₹295 as the first target and ₹310 as the second target, supported by the company’s expansion into new markets and diversified insurance products.
Q.4. What are the share price targets for Niva Bupa Health Insurance in 2028?
Ans: The expected share price targets for 2028 are ₹370 as the first target and ₹405 as the second target, fueled by growth in customer base and innovative insurance solutions.
Q.5. What is the forecast for Niva Bupa share price in 2029?
Ans: For 2029, the share price is anticipated to reach ₹460 as the first target and ₹500 as the second target, reflecting the company’s strengthening position in the health insurance sector.
Q.6. What are the share price targets for Niva Bupa Health Insurance in 2030?
Ans: By 2030, the share price is expected to achieve ₹560 as the first target and ₹590 as the second target, supported by increasing health awareness and government initiatives promoting insurance.
Q.7. What are the long-term share price targets for Niva Bupa Health Insurance in 2035?
Ans: For 2035, the share price is expected to reach ₹1050 as the first target and ₹1370 as the second target, reflecting significant growth in the Indian insurance market and Niva Bupa’s leadership position.
Q.8. What is the share price target for Niva Bupa Health Insurance in 2040?
Ans: By 2040, the share price is anticipated to reach ₹1700 as the first target and ₹2150 as the second target, driven by long-term demand for health insurance and Niva Bupa’s continued innovation and growth.
Q.9. Who is the CEO of Niva Bupa Health Insurance?
Ans: The Managing Director and CEO of Niva Bupa Health Insurance is Krishnan Ramachandran. He has been in this role since 2020 and brings over two decades of experience in the health insurance, healthcare, and life sciences sectors.
Q.10. What is the NSE & BSE code for Niva Bupa Health Insurance?
Ans: The company got listed on November 14, 2024. The NSE symbol is NIVABUPA. The BSE code is 544286.
TradeWatch360 is a premier platform dedicated to providing real-time insights, trends, and updates in the stock market. It is designed to support both new and seasoned investors by delivering timely and actionable information across a range of asset classes, including stocks, futures, commodities, and global markets.